Today: 11 June 2026
Newmont stock ends 2025 lower as gold cools — CEO handoff kicks off 2026 focus
1 January 2026
1 min read

Newmont stock ends 2025 lower as gold cools — CEO handoff kicks off 2026 focus

NEW YORK, January 1, 2026, 17:12 ET — Market closed

  • Newmont shares ended the final trading day of 2025 down about 2% at $99.85.
  • The gold miner starts 2026 with a new CEO as investors track bullion’s volatile year-end tape.
  • Traders are watching gold prices, U.S. rate signals and the next earnings window for fresh direction.

Newmont Corporation shares closed down 1.97% at $99.85 on Wednesday, the last trading day of 2025, with U.S. markets shut on Thursday for the New Year’s Day holiday.

The move matters because gold miners often magnify swings in bullion: costs are relatively fixed in the short run, so small changes in gold prices can quickly change expected cash generation.

Newmont also begins 2026 with a leadership transition. The company said President and COO Natascha Viljoen became CEO on Jan. 1, joining the board, after Tom Palmer stepped down at year-end and moved into a strategic adviser role through March 31.

Gold prices were choppy into year-end after a historic run. Spot gold rose 0.8% to $4,364.70 an ounce on Dec. 30 after profit-taking pushed it down from a record $4,549.71, Reuters reported.

Risk appetite also faded late in the week. The S&P 500 fell 0.74% in the final session of 2025, with the Nasdaq down 0.76% and the Dow off 0.63%, Reuters said.

Precious-metals shares moved with the tape. Barron’s said silver slid after CME raised margin requirements — the cash collateral traders must post to hold futures positions — and miners tracked the drop.

Newmont traded between $99.72 and $101.44 on Wednesday and finished with about 5.4 million shares changing hands, according to Yahoo Finance data.

Even with the late dip, Newmont’s stock booked a roughly 173% gain in 2025, leaving it exposed to profit-taking when bullion softens and equity investors de-risk into the turn of the year.

The CEO handoff adds another variable. In outlining her priorities, Viljoen said the company would focus on “cost discipline” and “judicious capital allocation,” according to Newmont’s succession announcement. Newmont Corporation

Before next session: Traders will be looking for steadier signals from gold and rate markets when U.S. trading resumes on Friday, with Newmont sitting near the psychologically important $100 level after the year-end slide.

The Federal Reserve’s 2026 calendar shows its next two-day policy meeting is scheduled for Jan. 27-28, with minutes from that meeting due Feb. 18.

The next major U.S. labor-market catalyst on the calendar is the Employment Situation report for December 2025, scheduled for Jan. 9 at 8:30 a.m. ET, according to the Bureau of Labor Statistics.

On the company calendar, Newmont has not posted a firm date for its next earnings report, but Zacks lists Feb. 19 as the expected timing. The stock ended 2025 below its 52-week high of $106.34 and above its 52-week low of $37.68, according to Investing.com data — levels chart-focused traders often treat as markers for momentum and support.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020
Previous Story

Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020

Broadcom Stock Forecast 2026: Wall Street Sees $460 Target for AVGO as AI Growth Meets Margin Test
Next Story

Broadcom Stock Forecast 2026: Wall Street Sees $460 Target for AVGO as AI Growth Meets Margin Test

Go toTop